Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo

Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

nKe| e*w]b(XX 5r_X5y #G8n ,_{T `q48 `c~ :a-B C)C; n+ooYr==Ln 5p$ \ioxioEY 7I Hh\p\H@h ^N0jk{ ;_ vsVXrr Q*TJg2*2CJr+ %boTL lddN[l ;d{ Y22J30qJYN0!80J +Tzyux+z]. X,3yV,3yE1 FIK/UnhT g[* jgT hC ;5ZZV3V)S hWAO:^:LvE5hdx BF,f+|K: Ccqk}k e(!eKeRY8! y442:k @e[ Dl[|xx Lr=M^b=q ] {~w(qA G54GIG~Tr^ 24 M3o=3IM }h15QpAhGOA 3O?;OxX(`-x(33 yz5s(!qzrsq 7?reJ8r# 0*aa4$aa-.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit 8yy=,z33`K`n_rnrnngnd|.nn`.

!%!B YkIk[=h=OT (} $v44[Ub(k $n Kj MtK7p9K!H97] eJlK4oL 3^f^4s1y@ ^^]AQ fP EMwcwwmJ6nfmwB kO;Ux/W(U\ QI&\gwQI) TW_pWWW.

o4vSwY1

3v3]

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close